Abstract: This corrigendum provides a formal update to the institutional affiliations for the study "Clinical and biological effects of tumor associated lymphocytes in the presence or absence of chemotherapy for malignant ascites in ovarian cancer patients," originally published in Oncology Letters in 2017 (DOI: 10.3892/ol.2017.6635). The correction ensures that Southern Medical University is recognized as the primary research site for the investigation into the immunological landscape of ovarian cancer.
Introduction
In the rigorous world of oncology research, the accurate attribution of institutional support is not merely a matter of administrative record; it is a fundamental requirement for scientific integrity. This document serves as a formal corrigendum for a research paper published in 2017 that explored the clinical and biological impacts of tumor-associated lymphocytes (TALs). The original study focused on ovarian cancer patients suffering from malignant ascites, examining how the presence or absence of chemotherapy influenced the behavior and efficacy of these immune cells.
The Nature of the Correction
Following the publication of the original article, the authors identified a significant error regarding the institutional affiliations of the research team. In academic publishing, the order in which institutions are listed often signifies the primary location of the research or the institution that provided the majority of the funding and infrastructure.
The authors noted that the Department of Medical Oncology at Nanfang Hospital, Southern Medical University, was the site where the bulk of the experimental work was conducted. Lead author Weiwei Zhang spearheaded the study at this location. However, in the initial 2017 version, the institutional addresses were not ordered to reflect this priority. This corrigendum rectifies the error by reordering the affiliations to establish Southern Medical University as the primary (1st) address.
Institutional and Collaborative Context
The corrected affiliation block reveals a complex and collaborative network of Chinese medical and technological institutions. This collaboration was essential for the multi-faceted approach required to study TALs in the context of chemotherapy. The key institutions involved include:
- Nanfang Hospital, Southern Medical University: The primary site for the experimental research.
- The Sixth People’s Hospital of Chengdu: The secondary affiliation for lead author Weiwei Zhang.
- Dongguan People’s Hospital: A contributing clinical partner.
- University of Electronic Science and Technology of China: Contributing through the School of Life Science and Technology.
By correcting the record, the authors ensure that each of these institutions receives the appropriate recognition for their specific contributions to the study of ovarian cancer immunology.
Significance of the Update
While the scientific findings—concerning the biological effects of TALs and their interaction with chemotherapeutic agents—remain unchanged, the correction of institutional data is vital. Institutional credit is a key metric used for university rankings, the allocation of government and private research grants, and the professional advancement of the scientists involved.
Furthermore, this corrigendum highlights the self-correcting mechanism of the scientific community. Even after a paper has been in the public domain for a year or more, authors and journals remain committed to ensuring that every detail of the bibliographic record is precise. This transparency is crucial for maintaining the trust of the scientific community and the public.
Conclusion
The 2018 publication of this corrigendum ensures that the historical record of the research into tumor-associated lymphocytes in ovarian cancer is accurate. The authors have expressed their apologies for any confusion caused by the initial misordering of affiliations. This update reinforces the status of Southern Medical University as a leading center for the research described in the original 2017 study.
Note: This summary refers to the corrigendum for the article with DOI: 10.3892/ol.2017.6635.
Summary updated